Prognostic Modeling of Individual Patient Risk and Mortality Impact of Ischemic and Hemorrhagic Complications-Reference-Cited by-同舟云学术

Prognostic Modeling of Individual Patient Risk and Mortality Impact of Ischemic and Hemorrhagic Complications

Published:2010-01-05 Issue:1 Volume:121 Page:43-51
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

Pocock Stuart J.¹,Mehran Roxana¹,Clayton Tim C.¹,Nikolsky Eugenia¹,Parise Helen¹,Fahy Martin¹,Lansky Alexandra J.¹,Bertrand Michel E.¹,Lincoff A. Michael¹,Moses Jeffrey W.¹,Ohman E. Magnus¹,White Harvey D.¹,Stone Gregg W.¹

Affiliation:

1. From the London School of Hygiene and Tropical Medicine, London, UK (S.J.P., T.C.C.); Columbia University Medical Center and Cardiovascular Research Foundation, New York, NY (R.M., E.N., H.P., M.F., A.J.L., J.W.M., G.W.S.); Hopital Cardiologique, Lille, France (M.E.B.); The Cleveland Clinic, Cleveland, Ohio (A.M.L.); Duke University Medical Center, Durham, NC (E.M.O.); and Auckland City Hospital, Auckland, New Zealand (H.D.W.).

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference30 articles.

1. Adverse Impact of Bleeding on Prognosis in Patients With Acute Coronary Syndromes

2. Impact of Bleeding Severity on Clinical Outcomes Among Patients With Acute Coronary Syndromes

3. A Comparison of the Clinical Impact of Bleeding Measured by Two Different Classifications Among Patients With Acute Coronary Syndromes

4. Periprocedural Bleeding and 1-Year Outcome After Percutaneous Coronary Interventions

5. Routine Upstream Initiation vs Deferred Selective Use of Glycoprotein IIb/IIIa Inhibitors in Acute Coronary Syndromes

Cited by 110 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacologic targeting of coagulation factors XII and XI by monoclonal antibodies reduces thrombosis in nitinol stents under flow;Journal of Thrombosis and Haemostasis;2024-05

2. Quantifying the benefit-risk trade-off for individual patients in a clinical trial: principles and antithrombotic case study;Journal of Thrombosis and Haemostasis;2024-05

3. Impact of Periprocedural Adverse Events After PCI and CABG on 5-Year Mortality;JACC: Cardiovascular Interventions;2023-02

4. Incidence, Predictors and Associations Between In-Hospital Bleeding and Adverse Events in Patients with Acute Coronary Syndrome Above 75 Years of Age – The Real-World Scenario;Cardiovascular Innovations and Applications;2023

5. Self-reported non-adherence to P2Y12 inhibitors in patients undergoing percutaneous coronary intervention: Application of the medication non-adherence academic research consortium classification;PLOS ONE;2022-02-16